Literature DB >> 25105337

Decreased incidence of venous thromboembolism after spine surgery with early multimodal prophylaxis: Clinical article.

J Bridger Cox1, Kristin J Weaver, Daniel W Neal, R Patrick Jacob, Daniel J Hoh.   

Abstract

OBJECT: Venous thromboembolism (VTE) represents a significant complication after spine surgery, with reported rates as high as 2%-4%. Published institutional practices for VTE prophylaxis are highly variable. In 2008, the authors implemented a departmental protocol for early VTE prophylaxis consisting of combined compressive devices and subcutaneous heparin initiated either preoperatively or on the same day of surgery. In this study, the authors compared the incidence of VTE in spine surgery patients before and after implementing this protocol.
METHODS: An institutional review board-approved retrospective review of outcomes in patients undergoing spine surgery 2 years before protocol implementation (representing the preprotocol group) and of outcomes in patients treated 2 years thereafter (the postprotocol group) was conducted. Inclusion criteria were that patients were 18 years or older and had been admitted for 1 or more days. Before 2008 (preprotocol), VTE prophylaxis was variable and provider dependent without any uniform protocol. Since 2008 (postprotocol), a new VTE-prophylaxis protocol was administered, starting either preoperatively or on the same day of surgery and continuing throughout hospitalization. The new protocol consisted of 5000 U heparin administered subcutaneously 3 times daily, except in patients older than 75 years or weighing less than 50 kg, who received this dose twice daily. All patients also received sequential compression devices (SCDs). The incidence of VTE in the 2 protocol phases was identified by codes of the International Classification of Diseases, Ninth Revision (ICD-9) codes for deep vein thrombosis (DVT) and pulmonary embolus (PE). Bleeding complications arising from anticoagulation treatments were evaluated by the Current Procedural Terminology (CPT) code for postoperative epidural hematoma (EDH) requiring evacuation.
RESULTS: In total, 941 patients in the preprotocol group met the inclusion criteria: 25 had DVT (2.7%), 6 had PE (0.6%), and 6 had postoperative EDH (0.6%). In the postprotocol group, 992 patients met the criteria: 10 had DVT (1.0%), 5 had PE (0.5%), and 4 had postoperative EDH (0.4%). This reduction in DVT after the protocol's implementation was statistically significant (p = 0.009). Despite early aggressive prophylaxis, the incidence of postoperative EDH did not increase and compared favorably to the published literature.
CONCLUSIONS: At a high-volume tertiary center, an aggressive protocol for early VTE prophylaxis after spine surgery decreases VTE incidence without increasing morbidity.

Entities:  

Keywords:  CPT = Current Procedural Terminology; CS = compression stocking; DVT = deep vein thrombosis; EDH = epidural hematoma; LOS = length of stay; PE = pulmonary embolus; SCD = sequential compression device; VTE = venous thromboembolism; deep venous thrombosis; hospital-acquired condition; patient quality; pulmonary embolism; spinal disorders; spine surgery; venous thromboembolism

Mesh:

Year:  2014        PMID: 25105337     DOI: 10.3171/2014.6.SPINE13447

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  25 in total

1.  Medication reconciliation for patients undergoing spinal surgery.

Authors:  Pamela Kantelhardt; Alf Giese; Sven R Kantelhardt
Journal:  Eur Spine J       Date:  2015-03-21       Impact factor: 3.134

2.  [Pre- and postoperative fast-track treatment concepts in spinal surgery : patient information and patient cooperation].

Authors:  C Fleege; M Arabmotlagh; A Almajali; M Rauschmann
Journal:  Orthopade       Date:  2014-12       Impact factor: 1.087

3.  A predictive model of preoperative risk factors for venous thromboembolism after fusion for degenerative conditions of the thoracolumbar spine.

Authors:  McKayla Kelly; Alessandro Speciale; Chad Patton; Justin Turcotte
Journal:  J Orthop       Date:  2020-11-19

4.  Perioperative Anticoagulation Management in Spine Surgery: Initial Findings From the AO Spine Anticoagulation Global Survey.

Authors:  Philip Louie; Garrett Harada; James Harrop; Thomas Mroz; Khalid Al-Saleh; Giovanni Barbanti Brodano; Jens Chapman; Michael Fehlings; Serena Hu; Yoshiharu Kawaguchi; Michael Mayer; Venugopal Menon; Jong-Beom Park; Sheeraz Qureshi; Shanmuganathan Rajasekaran; Marcelo Valacco; Luiz Vialle; Jeffrey C Wang; Karsten Wiechert; K Daniel Riew; Dino Samartzis
Journal:  Global Spine J       Date:  2020-04-17

5.  Venous Thromboembolism After Degenerative Spine Surgery: A Nationwide Readmissions Database Analysis.

Authors:  Ian A Buchanan; Michelle Lin; Daniel A Donoho; Li Ding; Steven L Giannotta; Frank Attenello; William J Mack; John C Liu
Journal:  World Neurosurg       Date:  2019-01-23       Impact factor: 2.104

6.  Prevalence and risk factors of deep vein thrombosis in patients after spine surgery: a retrospective case-cohort study.

Authors:  Si-Dong Yang; Huan Liu; Ya-Peng Sun; Da-Long Yang; Yong Shen; Shi-Qing Feng; Feng-Dong Zhao; Wen-Yuan Ding
Journal:  Sci Rep       Date:  2015-07-02       Impact factor: 4.379

7.  Surgical Factors Associated with Prolonged Hospitalization after Reconstruction for Oncological Spine Surgery.

Authors:  Hannah M Carl; Devin Coon; Nicholas A Calotta; Rachel Pedreira; Justin M Sacks
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-04-07

8.  Comparison of apixaban and rivaroxaban for anticoagulant effect after lumbar spine surgery: a single-center report.

Authors:  Kun Zhang; Shenghao Zhao; Wusheng Kan; Jun Xiao; Feifei Pu; Kun Li
Journal:  Future Sci OA       Date:  2018-03-14

9.  Prophylactic inferior vena cava filter placement prior to lumbar surgery in morbidly obese patients: Two-case study and literature review.

Authors:  Nancy E Epstein
Journal:  Surg Neurol Int       Date:  2015-10-08

10.  Prevalence and Risk Factors of Deep Vein Thrombosis in Patients Undergoing Lumbar Interbody Fusion Surgery: A Single-Center Cross-Sectional Study.

Authors:  Si-Dong Yang; Wen-Yuan Ding; Da-Long Yang; Yong Shen; Ying-Ze Zhang; Shi-Qing Feng; Feng-Dong Zhao
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.